AngioDynamics Announces Secondary Offering Of 2,250,000 Shares Of Common Stock By Selling Stockholders

AngioDynamics, Inc., today announced that Avista Capital Partners, LP and affiliated investment funds intend to offer for sale 2,250,000 shares of common stock in an underwritten secondary offering.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.